Folotyn for Non-Hodgkin's Lymphoma Wyandanch NY

The drug Folotyn (pralatrexate) has been approved to treat Peripheral T-cell Lymphoma (PTCL), an often aggressive form of non-Hodgkin's lymphoma, the U.S. Food and Drug Administration said Friday. The drug, given accelerated approval because it treats an unmet medical need, was sanctioned for people whose disease has returned or hasn't responded to other types of chemotherapy, the agency said in a news release.

Local Companies

JAGADAMMA NAIR, MD
(516) 572-6131
2201 Hempstead Turnpike
East Meadow, NY
HARRY STASZEWSKI, MD
(516) 663-9500
200 Old Country Road
Mineola, NY
TARUN WASIL, MD
(516) 354-2200
1575 Hillside Avenue
New Hyde Park, NY
Sagun Shrestha, MD
718-470-7700
275-05 76th Ave
New Hyde Park, NY
Elisa Jiayi Wu, MD
212-639-7900
650 Commack Rd
Commack, NY
Charles Carmine Conte
(516) 487-9454
600 Northern Blvd
Great Neck, NY
TRIANTAFILLOS FILLOS, MD
(516) 627-1221
1201 Northern Boulevard
Manhasset, NY
MATTHEW KAUFMAN, MD
(516) 470-4050
410 Lakeville Road
New Hyde Park, NY
JOHN REILLY, MD
(516) 705-1353
1000 N. Village Avenue
Rockville Centre, NY
Moshe Weiner, MD
516-546-5000
2209 Merrick Rd
Merrick, NY
Data Provided by:
    

Provided By:

FRIDAY, Sept. 25 (HealthDay News) -- The drug Folotyn (pralatrexate) has been approved to treat Peripheral T-cell Lymphoma (PTCL), an often aggressive form of non-Hodgkin's lymphoma, the U.S. Food and Drug Administration said Friday.

The drug, given accelerated approval because it treats an unmet medical need, was sanctioned for people whose disease has returned or hasn't responded to other types of chemotherapy, the agency said in a news release.

PTCL strikes fewer than 9,500 people each year in the United States, the FDA said. The disease affects a type of white blood cell, called a T-cell, involved in the body's disease-fighting immune system.

Approval of Folotyn was based on clinical data showing it reduced tumor size in 27 percent of 109 people with PTCL who were studied. The most common adverse reactions included sores of the lips, mouth and digestive tract, low white blood cell counts, fever, nausea and fatigue.

Since the drug can harm a fetus, women taking Folotyn should avoid becoming pregnant, the FDA said. Anyone taking the drug should also take folate and vitamin B12 supplements to help reduce irritation of the mucous membranes.

Folotyn is produced by Colorado-based Allos Therapeutics, which is required to conduct additional studies of tumor shrinkage and life expectancy, the agency said.

More information

The FDA has more about this drug.

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com

Related Articles
- Green Tea and Hematologic Malignancies Wyandanch NY
Read more about Green Tea May Lower the Risk of Hematologic Malignancies.
- Donor Stem-Cell Transplant for Acute Myeloid Leukemia Wyandanch NY